These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29508211)

  • 1. Ligand-Based Pharmacophore Screening Strategy: a Pragmatic Approach for Targeting HER Proteins.
    James N; Ramanathan K
    Appl Biochem Biotechnol; 2018 Sep; 186(1):85-108. PubMed ID: 29508211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Design for ALK-Positive NSCLC: an Integrated Pharmacophore-Based 3D QSAR and Virtual Screening Strategy.
    James N; Shanthi V; Ramanathan K
    Appl Biochem Biotechnol; 2018 May; 185(1):289-315. PubMed ID: 29134510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
    Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
    Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density Functional Theory and Molecular Simulation Studies for Prioritizing Anaplastic Lymphoma Kinase Inhibitors.
    James N; Shanthi V; Ramanathan K
    Appl Biochem Biotechnol; 2020 Apr; 190(4):1127-1146. PubMed ID: 31712989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics Strategy.
    James N; Ramanathan K
    Cell Biochem Biophys; 2018 Jun; 76(1-2):111-124. PubMed ID: 28477056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches.
    Rampogu S; Son M; Baek A; Park C; Rana RM; Zeb A; Parameswaran S; Lee KW
    Comput Biol Chem; 2018 Jun; 74():327-338. PubMed ID: 29702367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations.
    Katari SK; Natarajan P; Swargam S; Kanipakam H; Pasala C; Umamaheswari A
    J Recept Signal Transduct Res; 2016 Dec; 36(6):558-571. PubMed ID: 26906522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel lead molecules against RhoG protein as cancer target - a computational study.
    Dasari T; Kondagari B; Dulapalli R; Abdelmonsef AH; Mukkera T; Padmarao LS; Malkhed V; Vuruputuri U
    J Biomol Struct Dyn; 2017 Nov; 35(14):3119-3139. PubMed ID: 27691842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer.
    Singh PK; Silakari O
    J Mol Model; 2018 Oct; 24(11):318. PubMed ID: 30343450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling.
    Zalloum H; Tayyem R; Irmaileh BA; Bustanji Y; Zihlif M; Mohammad M; Rjai TA; Mubarak MS
    J Mol Graph Model; 2015 Sep; 61():61-84. PubMed ID: 26188796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational screening, ensemble docking and pharmacophore analysis of potential gefitinib analogues against epidermal growth factor receptor.
    Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
    J Recept Signal Transduct Res; 2018 Feb; 38(1):48-60. PubMed ID: 29369008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents.
    Prabhavathi H; Dasegowda KR; Renukananda KH; Karunakar P; Lingaraju K; Raja Naika H
    J Biomol Struct Dyn; 2022 Jul; 40(10):4713-4724. PubMed ID: 33345701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective virtual screening strategy focusing on the identification of novel Bruton's tyrosine kinase inhibitors.
    Xiao J; Zhang S; Luo M; Zou Y; Zhang Y; Lai Y
    J Mol Graph Model; 2015 Jul; 60():142-54. PubMed ID: 26043662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics and integrated pharmacophore-based identification of dual [Formula: see text] inhibitors.
    Kaur M; Singh PK; Singh M; Bahadur R; Silakari O
    Mol Divers; 2018 Feb; 22(1):95-112. PubMed ID: 29138965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel scaffolds to inhibit human mitotic kinesin Eg5 targeting the second allosteric binding site using in silico methods.
    Makala H; Ulaganathan V
    J Recept Signal Transduct Res; 2018 Feb; 38(1):12-19. PubMed ID: 29041840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Novel Inhibitors Targeting the Menin-Mixed Lineage Leukemia Interface Using Pharmacophore- and Docking-Based Virtual Screening.
    Xu Y; Yue L; Wang Y; Xing J; Chen Z; Shi Z; Liu R; Liu YC; Luo X; Jiang H; Chen K; Luo C; Zheng M
    J Chem Inf Model; 2016 Sep; 56(9):1847-55. PubMed ID: 27513308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer.
    Yonesaka K; Kudo K; Nishida S; Takahama T; Iwasa T; Yoshida T; Tanaka K; Takeda M; Kaneda H; Okamoto I; Nishio K; Nakagawa K
    Oncotarget; 2015 Oct; 6(32):33602-11. PubMed ID: 26418897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Autophagy Specific Lipid Kinase VPS34 for Cancer Treatment: An Integrative Repurposing Strategy.
    Murali P; Verma K; Rungrotmongkol T; Thangavelu P; Karuppasamy R
    Protein J; 2021 Feb; 40(1):41-53. PubMed ID: 33400087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.